MedPath

Effect of Simvastatin gel in treatment of acne

Phase 2
Recruiting
Conditions
Acne Vulgaris.
Acne vulgaris
Registration Number
IRCT20100119003106N38
Lead Sponsor
Islamic Azad University, Pharmaceutical Sciences Branch
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Patients with mild and moderate acne vulgaris

Exclusion Criteria

Pregnant women
Breastfeeding women
The patients with dermatological malignancy
The patients with burning
The patients with infection
The patients which have known hypersensitivity to simvastatin
The patients which have received any topical or oral medications for acne vulgaris in the last one month

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acne scores in the Global Acne Grading System. Timepoint: Before intervention and 2, 5 , 8 weeks after intervention. Method of measurement: The Global Acne Grading System Formula.
Secondary Outcome Measures
NameTimeMethod
Quality of life score. Timepoint: Before intervention and 2, 5, 8 weeks after intervention. Method of measurement: The Cardiff Acne Disability Index questionnaire.
© Copyright 2025. All Rights Reserved by MedPath